RecruitingNCT05039216
Biobank for Inflammatory Chronic Diseases and Osteoporosis
Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse
Sponsor
University Hospital, Toulouse
Enrollment
2,000 participants
Start Date
Sep 13, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria3
- Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
- With National Health Assurance
- Able to consent to the study
Exclusion Criteria3
- Pregnancy or breastfeeding
- Not able to give a consent
- Severe anemia (Hb\<10g/L)
Interventions
BIOLOGICALBlood sampling
4 tubes of 7 mL will be sampled
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05039216
Related Trials
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
NCT068415621 location
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
NCT0710093829 locations
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT0691680633 locations
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
NCT066316385 locations